Keep Us Strong WikiLeaks logo

Currently released so far... 64621 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse by classification

Community resources

courage is contagious

Viewing cable 05ANKARA2126, COMMISSION ON NARCOTICS DRUGS: REQUEST FOR US

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05ANKARA2126.
Reference ID Created Released Classification Origin
05ANKARA2126 2005-04-14 08:12 2011-08-24 01:00 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Ankara
This record is a partial extract of the original cable. The full text of the original cable is not available.

140812Z Apr 05
UNCLAS ANKARA 002126 
 
SIPDIS 
 
SENSITIVE 
 
E.O. 12958: N/A 
TAGS: SNAR PREL AORC TU
SUBJECT: COMMISSION ON NARCOTICS DRUGS: REQUEST FOR US 
SUPPORT FOR TURKEY'S RE-ELECTION 
 
 
This is an action request. 
 
1. (SBU) Summary:  Turkey has requested US support for its 
candidacy for re-election to the Commission on Narcotic Drugs 
(CND) at ECOSOC.  Post recommends favorable consideration, 
given Turkey's critical location along a main route for drug 
flows from Afghanistan.  Turkey is also one of only two 
countries in the world authorized legal opiate production. 
U.S. support would also help reinforce bilateral 
counternarcotics cooperation.  End Summary. 
 
2. (SBU) In a March 28 diplomatic note, the Foreign Ministry 
requested U.S. support for Turkey's candidacy for re-election 
to ECOSOC's Commission on Narcotic Drugs (CND) for the 
2006-09 term.  In addition to sending the note, Ambassador 
Hayati Guven, MFA Director General for Security Affairs, 
raised the issue with the DCM.  The MFA offices that handle 
international organizations and narcotics have also made a 
point of requesting U.S. support.  The MFA officials told us 
they are concerned that, with six candidates from the WEOG 
group (Australia, Canada, England, Belgium, Spain and Turkey) 
but only five spots, Turkey is in danger of losing its place 
on the commission. 
 
3. (SBU) The GOT argues that it is a strong candidate for 
several reasons: 
 
--location along the principal route for egress of drugs from 
Afghanistan; 
 
--status as one of two countries authorized to produce 
opiates legally; 
 
--commitment to counter-narcotics demonstrated by its new 
status as a "Major Donor" at UNODC, having given $500,000 in 
each of the last two years; 
 
--decision to join the Paris Pact and host a conference later 
this year; 
 
--substantial resources devoted to TADOC, the regional 
training center located in Ankara at which over 1,000 foreign 
students have received training. 
 
4. (SBU) Post suggests that Washington favorably consider 
Turkey's request.  With the recent surge of drugs from 
Afghanistan, it would send a bad message if Turkey were not 
to be re-elected to the CND, and particularly so if it is 
replaced by a country with a less central role in global 
narcotics issues.  US support for Turkey would also reinforce 
our excellent cooperation in counternarcotics.  The timing 
would be particularly good given the GOT's recent frustration 
of its candidacy for the Directorship of the Southeast 
European Cooperation Initiative (SECI). 
EDELMAN